David Higgins, CIRM Board member and Patient Advocate for Parkinson's disease; Photo courtesy San Diego Union Tribune The California Institute for Regenerative Medicine (CIRM) board approved $16 million for more than a dozen Discovery‑stage research programs. These projects span Parkinson’s disease, new drug targets for cancer stem cells, and methods for creating human airway stem … Continue reading CIRM Board Approves $16.4 million for Early Stage Discovery Research